Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Feature Stories

Latest Feature Stories

MSF vaccinated 31,126 children against measles during a 15 day campaign in the crowded slum area of Machar Colony, in Karachi, Pakistan. MSF has been running a primary and emergency healthcare and obstetric clinic in Machar Colony since 2012. Photograph by Husni Mubarak Zainal Photograph by Husni Mubarak Zainal
Feature story
Feature story |
10 March 2016
Hepatitis C
Pakistan

Pakistan: Interview with Dr Muhammed Khawar Aslam on treating Hep C in MSF’s Machar Clinic, Karachi

6 min
Noor Alam (pictured here with his son) was cured of Hepatitis C at MSF's Machar Clinic in Pakistan in 2016 after recieving a generic version of sofosbuvir. Gilead has priced sofosbuvir at $1,000 per pill in the U.S., despite the fact that manufacturers in India say they could produce this drug for as little as about $1 per pill. Photograph by Sa'adia Khan
Feature story
Feature story |
10 March 2016
Hepatitis C
Pakistan

Pakistan: Stories from patients cured from hepatitis C in MSF's Machar Clinic in Karachi

5 min
Portrait of Portrait of Bwa Mpana, 37, a patient at the Mbankana General Hospital in Kinshasa, DRC, since 2011. Photograph by Sandra Smiley
Feature story
Feature story |
30 November 2015
HIV/AIDS
Democratic Republic of the CongoMalawiMozambiqueSouth Africa

Stockouts testimonies

6 min
Dr Abdulfattah Al-Alimi Field coordinator and medical team leader of the Médecins Sans Frontières (MSF) HIV/AIDS project in Yemen Photograph by Anna Surinyach
Feature story
Feature story |
29 October 2015
HIV/AIDS
Yemen

Yemen: antiretroviral treatment beneath the bombs

6 min
MSF mobile medical team crosses the river with cars and motorbikes to reach remote villages. Photograph by Philipp Frisch
Feature story
Feature story |
16 September 2015
Tropical & neglected diseases
Democratic Republic of the Congo

MSF travels the extra mile to treat sleeping sickness in Democratic Republic of Congo

4 min
Medical Team Leader Tatyana Pylypenko and staff members distribute toys donated to MSF in a TB children’s ward in Nukus, Uzbekistan. Photograph by Rolan Abipov Photograph by Rolan Abipov
Feature story
Feature story |
06 August 2015
Tuberculosis
UkraineUzbekistan

TB in Uzbekistan: "The regimen is long and arduous"

National staff members dressed in PPE attend to a 16 year old girl confirmed with Ebola, in Sierra Leone, 2015 Photograph Fabio Basone
Feature story
Feature story |
06 August 2015
Vaccines
GuineaLiberiaSierra Leone

Q&A: Getting Closer to an Ebola Vaccine

4 min
A cholera vaccination campaign to protect refugees in the overflowing Nyarugusu camp in Tanzania has been completed on the 27th of july 2015. More than 130 000 person have been vaccinated in less than a week. This was the second round of the campaign, in response to an outbreak that occurred among the refugees in May this year. Photograph by Louise Annaud Photograph by Louise Annaud
Feature story
Feature story |
30 July 2015
Vaccines

Tanzania: 130,000 refugees vaccinated against cholera in the overcrowded Nyarugusu camp

3 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury